Leukemia

Oncology & Cancer

New insights into T-cell acute lymphoblastic leukaemia development

A research team from the National University of Singapore (NUS) led by Assistant Professor Takaomi Sanda, Principal Investigator from the Cancer Science Institute of Singapore and Department of Medicine at NUS Yong Loo Lin ...

Oncology & Cancer

An epigenetic lesion could be responsible for acute T-cell leukemia

Researchers from the Epigenetics and Cancer Biology Program (PEBC) led by Dr. Manel Esteller at the Bellvitge Biomedical Research Institute (IDIBELL) have discovered how an epigenetic lesion can lead to T-cell acute lymphoblastic ...

Oncology & Cancer

Researchers show p300 protein may suppress leukemia in MDS patients

Scientists at Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine have shown that p300, a protein that increases gene expression by attaching acetyl molecules to DNA, may stop myelodysplastic ...

Oncology & Cancer

AML study correlates gene mutations with 34 disease subgroups

A large, new study of adults with acute myeloid leukemia (AML) correlates 80 cancer-related gene mutations with five subtypes of AML, which are defined by the presence of specific chromosomal abnormalities. The findings might ...

Medical research

Research uncovers potential health risks of travel to Mars

Sending a manned mission to Mars requires more than a powerful launch rocket. Prep work also includes learning how a three-year space flight could affect the human body. With funding from the National Aeronautics and Space ...

Oncology & Cancer

Metabolism drives growth and division of cancer cells

The metabolic state of tumor cells contributes to signals that control their proliferation. German biochemist and Nobel Prize laureate Otto H. Warburg observed in the 1920s that tumor cells radically change their metabolism. ...

Oncology & Cancer

Aggressive form of leukemia linked to defective 'protein factory'

Twenty to forty percent of the patients with the type of leukaemia known as multiple myeloma have a defect in the 'protein factory' of the cell: the ribosome. These patients have a poorer prognosis than patients with intact ...

page 7 from 9